152 related articles for article (PubMed ID: 37493735)
1. Association of PI3K/AKT/mTOR pathway autophagy-related gene polymorphisms with pulmonary tuberculosis susceptibility in a Chinese population.
He J; Liu S; Guo X; Zhang F; Fan Y; Wu L; Takiff HE; Zhao Y
Rev Soc Bras Med Trop; 2023; 56():e01042023. PubMed ID: 37493735
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants of autophagy-related genes in the PI3K/Akt/mTOR pathway and risk of gastric cancer in the Chinese population.
Zheng W; Wu C; Wu X; Cai Y; Liu B; Wang C
Gene; 2021 Feb; 769():145190. PubMed ID: 33053421
[TBL] [Abstract][Full Text] [Related]
3. The associations of hub gene polymorphisms in PI3K/AKT/mTOR pathway and Schistosomiasis Japonica infection and hepatic fibrosis.
Xiao Q; Yu H; Zhu X
Infect Genet Evol; 2020 Nov; 85():104423. PubMed ID: 32554084
[TBL] [Abstract][Full Text] [Related]
4. Putative functional variants of PI3K/AKT/mTOR pathway are associated with knee osteoarthritis susceptibility.
Wang K; Chu M; Wang F; Zhao Y; Chen H; Dai X
J Clin Lab Anal; 2020 Jun; 34(6):e23240. PubMed ID: 32052902
[TBL] [Abstract][Full Text] [Related]
5. Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survival.
Pande M; Bondy ML; Do KA; Sahin AA; Ying J; Mills GB; Thompson PA; Brewster AM
Breast Cancer Res Treat; 2014 Sep; 147(2):381-7. PubMed ID: 25108739
[TBL] [Abstract][Full Text] [Related]
6.
Zhang RR; Liang L; Chen WW; Wen C; Wan BS; Luo LL; Zhao YL; Chen J; Yue J
Int J Tuberc Lung Dis; 2019 Feb; 23(2):265-271. PubMed ID: 30808462
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population.
Xu JL; Wang ZW; Hu LM; Yin ZQ; Huang MD; Hu ZB; Shen HB; Shu YQ
Asian Pac J Cancer Prev; 2012; 13(5):2157-62. PubMed ID: 22901187
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in PI3K/Akt/mTOR pathway genes contribute to gastric cancer risk.
Ge Y; Liu H; Qiu X; Ma G; Wang H; Du M; Wang M; Zhao Q; Tao G; Chu H; Zhang Z
Gene; 2018 Sep; 670():130-135. PubMed ID: 29802999
[TBL] [Abstract][Full Text] [Related]
10. Associations of genetic polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer risk: A meta-analysis in Asian population.
Zhang Z; Chen Q; Zhang J; Wang Y; Hu X; Yin S; He M; Guan S; Qin W; Xiao Q; Zhao H; Yao W; Wu H; Wei M
Sci Rep; 2017 Dec; 7(1):17844. PubMed ID: 29259266
[TBL] [Abstract][Full Text] [Related]
11. IRGM gene polymorphisms and haplotypes associate with susceptibility of pulmonary tuberculosis in Chinese Hubei Han population.
Yuan L; Ke Z; Ma J; Guo Y; Li Y
Tuberculosis (Edinb); 2016 Jan; 96():58-64. PubMed ID: 26786655
[TBL] [Abstract][Full Text] [Related]
12. The PI3K/AKT/mTOR pathway regulates autophagy to induce apoptosis of alveolar epithelial cells in chronic obstructive pulmonary disease caused by PM2.5 particulate matter.
Zhang F; Ma H; Wang ZL; Li WH; Liu H; Zhao YX
J Int Med Res; 2020 Jul; 48(7):300060520927919. PubMed ID: 32715876
[TBL] [Abstract][Full Text] [Related]
13. AKT1 polymorphisms are associated with tuberculosis in the Chinese population.
Wang X; Cao Z; Jiang J; Zhu Y; Dong M; Tong A; Cheng X
Int J Immunogenet; 2010 Apr; 37(2):97-101. PubMed ID: 20141546
[TBL] [Abstract][Full Text] [Related]
14. Study on the association between PI3K/AKT/mTOR signaling pathway gene polymorphism and susceptibility to gastric cancer.
Qi L; Sun K; Zhuang Y; Yang J; Chen J
J BUON; 2017; 22(6):1488-1493. PubMed ID: 29332342
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer.
Kim JG; Chae YS; Sohn SK; Kang BW; Moon JH; Lee SJ; Jeon SW; Park JS; Park JY; Choi GS
Oncology; 2010; 79(3-4):278-82. PubMed ID: 21412012
[TBL] [Abstract][Full Text] [Related]
16. Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk.
Chen M; Cassidy A; Gu J; Delclos GL; Zhen F; Yang H; Hildebrandt MA; Lin J; Ye Y; Chamberlain RM; Dinney CP; Wu X
Carcinogenesis; 2009 Dec; 30(12):2047-52. PubMed ID: 19875696
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population.
Chen J; Shao P; Cao Q; Li P; Li J; Cai H; Zhu J; Wang M; Zhang Z; Qin C; Yin C
PLoS One; 2012; 7(7):e40817. PubMed ID: 22815832
[TBL] [Abstract][Full Text] [Related]
18. Association of
Cheng S; Sun C; Lao W; Kang H
Genet Test Mol Biomarkers; 2019 May; 23(5):299-303. PubMed ID: 30945947
[No Abstract] [Full Text] [Related]
19. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development.
Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S
IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations in the PI3K-PTEN-AKT-mTOR pathway are associated with distant metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
Guo Q; Lu T; Chen Y; Su Y; Zheng Y; Chen Z; Chen C; Lin S; Pan J; Yuan X
Sci Rep; 2016 Nov; 6():37576. PubMed ID: 27876891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
